Andrew Conrad Ph.D Overview
- Firm
- S32
- Primary Position
-
General Partner
- Primary Industry
-
Healthcare
- Active Board Seats
-
1
- Med. Deal Size
-
- Med. Valuation
-
Andrew Conrad Ph.D General Information
Biography
Dr. Andrew Conrad serves as General Partner at S32. Dr. Conrad serves as Board Member at Genalyte. Dr. Andrew Conrad is a Co-Founder of Verily Life Sciences. He serves as a Board Member at Genalyte. He also serves as a Board Member at Genalyte. He oversees an integrated team of engineers, scientists, designers, and medical experts working on a wide spectrum of healthcare-related projects. He was also the Co-Founder and served as the Chief Scientific Officer at the National Genetics Institute. Formerly the chief scientific officer of LabCorp, he is a cell biologist with a doctorate from UCLA. He has always been passionate about the early detection and prevention of disease. He co-founded the National Genetics Institute, which developed the first cost-effective test to screen for HIV in the blood supply. He also served on the Scientific Advisory Board of Medicxi's funds. He is a Working Group Member on the Precision Medicine Initiative and a member of the UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (CERSI) Scientific Advisory Board.
Contact Information
Address
- 169 University Avenue
- CA 94301
- United States
Andrew Conrad Ph.D Positions (2)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
S32 | Investor | General Partner | CA | Venture Capital | |
Verily Life Sciences | Company | Co-Founder | Dallas, TX | Monitoring Equipment |
Andrew Conrad Ph.D Board Seats (2)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Genalyte | Laboratory Services (Healthcare) | Privately Held (backing) | Venture Capital-Backed | San Diego, CA | |
SynapDx | Laboratory Services (Healthcare) | Out of Business | Formerly VC-backed | Lexington, MA |
Andrew Conrad Ph.D Lead Partner on Deals (3)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Genalyte | 06-Mar-2023 | Later Stage VC (Series C2) | Completed | Laboratory Services (Healthcare) | San Diego, CA | |
Granular Insurance Company | 29-Sep-2022 | Completed | Other Insurance | South San Francisco, CA | ||
Genalyte | 11-Jan-2021 | Completed | Laboratory Services (Healthcare) | San Diego, CA |
Andrew Conrad Ph.D Network (48)
Board Members (24)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Daniel O'Day | Flatiron | Roche | New York, NY | |
Vijit Sabnis Ph.D | Genalyte | Khosla Ventures | San Diego, CA | |
Genalyte | Genalyte | San Diego, CA | ||
Genalyte | Genalyte | San Diego, CA | ||
SynapDx | Self | Lexington, MA |
Portfolio Executives (24)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Brett Brown | Genalyte | Vice President, Finance | 06-Mar-2023 | San Diego, CA |
Sam Rutten | Genalyte | Vice President of Finance and People Operations | 06-Mar-2023 | San Diego, CA |
Genalyte | Head of Sales & Marketing | 06-Mar-2023 | San Diego, CA | |
Genalyte | Founder & Board Member | 06-Mar-2023 | San Diego, CA | |
Genalyte | Vice President of Clinical Assay Development | 06-Mar-2023 | San Diego, CA |
Andrew Conrad Ph.D FAQs
-
Who is Andrew Conrad Ph.D?
Dr. Andrew Conrad serves as General Partner at S32.
-
How much does Andrew Conrad Ph.D typically invest?
Andrew Conrad Ph.D's median deal size is
. -
What is Andrew Conrad Ph.D’s main position?
Andrew Conrad Ph.D’s primary position is General Partner.
-
How many active board seats does Andrew Conrad Ph.D hold?
Andrew Conrad Ph.D holds 2 board seats including Genalyte and SynapDx.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »